MARKET

HCM

HCM

Hutchmed (China) Limited
NASDAQ
11.44
+0.66
+6.12%
After Hours: 11.44 0 0.00% 16:10 07/02 EDT
OPEN
11.32
PREV CLOSE
10.78
HIGH
11.64
LOW
11.23
VOLUME
104.61K
TURNOVER
--
52 WEEK HIGH
19.50
52 WEEK LOW
9.77
MARKET CAP
2.00B
P/E (TTM)
4.371
1D
5D
1M
3M
1Y
5Y
1D
Weekly Buzz: VRTX, APTX Gain FDA Nod; UNCY Disappoints; Ipsen Opens Wallet; VTGN Misses Goal
NASDAQ · 2d ago
At a glance: stocks gapping up premarket
Seeking Alpha · 2d ago
Hutchmed announces China NMPA approval for Orpathys NDA
TipRanks · 2d ago
HUTCHMED says China regulator grants conditional approval for ORPATHYS in MET-amplified gastric cancer
PUBT · 2d ago
HUTCHMED ANNOUNCES NMPA APPROVAL FOR ORPATHYS® FOR THE TREATMENT OF GASTRIC CANCER PATIENTS WITH MET AMPLIFICATION
Reuters · 2d ago
HUTCHMED schedules webcast presentation following interim results announcement
PUBT · 4d ago
HUTCHMED to Announce 2026 Half-Year Financial Results
Barchart · 4d ago
Weekly Report: what happened at HCM last week (0622-0626)?
Weekly Report · 5d ago
More
About HCM
HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.

Webull offers HUTCHMED (China) Ltd (ADR) stock information, including NASDAQ: HCM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCM stock methods without spending real money on the virtual paper trading platform.